Jennifer Poon

Jennifer Poon has a diverse work experience in the field of regulatory affairs, spanning various pharmaceutical and biotechnology companies. Their most recent role is as the Senior Director of Regulatory Affairs at Cullinan Oncology, a position they have held since November 2022. Before joining Cullinan Oncology, Jennifer worked as the Regulatory Affairs Lead for Cellular Therapy at Imvax, Inc. from March 2021 to October 2022. Prior to that, they held the position of Associate Director of Regulatory Affairs at Ascentage Pharma from May 2019 to March 2021. Jennifer also gained experience at Allergan as part of the Global Regulatory Affairs team from October 2016 to May 2019. Earlier in their career, they worked in regulatory affairs roles at BioMarin Pharmaceutical Inc. from May 2015 to August 2016 and as a Post-Doctoral Fellow in Regulatory Affairs at Novartis from July 2013 to May 2015. Jennifer also served as an Adjunct Faculty member at Rutgers University from 2013 to 2015.

Jennifer Poon's education history includes earning a Doctor of Pharmacy (Pharm.D.) degree from Rutgers University. There is no specific information provided regarding the start and end years of their education at Rutgers University. Their field of study was Pharmacy.